Retail investors make good money in BEML FPO
Published on Tue, Jul 17, 2007 at 18:55 , Updated at Tue, Jul 17, 2007 at 19:04
Source : Moneycontrol.com
| ads by google |
The share opened at Rs 1199, down 2% as against its previous close of Rs 1223.75 and touched a high/low of Rs 1230.05 and Rs 1171.05, respectively. The share closed at Rs 1196.60, up 2.39% over its close of Rs 1168.65 on July 3, 2007. BEML had come out with an FPO of 46 lakh shares in the price band at Rs 1020-1090 and raised Rs 494.50 crore at the price of Rs 1075 per share. The issue had received overwhelming response, subscribed 30.65 times. The reserved portion of QIBs received 63 times subscription. HNIs portion subscribed 6.4 times and retail - 2.6 times.
For example If an investor invests Rs 98,100 in the issue by applying for 90 shares he would have been allotted only 33 shares (as per basis of allotment).The issue price is Rs 1075 per share. Today’s closing price is Rs 1196.6. It means that he would have gained Rs 4,012.8. ((Rs 1196.6 - Rs 1075) x 33 shares). So effectively the investor makes Rs 4,012.80 by investing Rs 98,100 for a period of 15 days. This is an absolute return of 4.09% but works out to an annualized return of 100%. Note: Issue closing date is July 3, 2007 and the shares of the FPO listed on July 17, 2007. The investor puts in the maximum application that he can in the retail category at the upper end of the price band. Sunil S Matkar - |
Messages on IPO, New Issues
Other comments
Its time to prepare shopping list guys !
Dear Guest, Yes , when you can make some good money in a very short period of thime and that too with certainity...
in IPO, New Issues - librankur at 13-Oct-08 11:52
India is not usa.Here 70% people are below poverty line .Tax payer money should reach to these people....
in IPO, New Issues - Guest at 12-Oct-08 07:33
Rate this article
News
13-10 Chemcel Biotech to double turnover by March-end
13-10 Chemcel Biotech ends with huge discount of 67.81%
Expert Advice
06-10 20 Microns fully priced at issue price
04-09 Austral Coke's fair value at discount to IPO price
Red Herring Document
| Company | Date |
| KSK Energy Ventures | 14-Feb-2008 |
| Lotus Eye Care Hospital | 01-Feb-2008 |
| Nu Tek India | 16-Jan-2008 |
| Bafna Pharmaceuticals | 27-Dec-2007 |
| Birla Cotsyn (India) | 27-Dec-2007 |
Chat
Ramesh Damani
Member BSE ,
(14 Oct- 16:00hrs)
What's good investment now?
Poll
Newsletter
Keep in touch with News day & night. Subscribe to:
Mobile Services
Get news on the move SMS to 52622
- SMS M for Market News
- SMS B for Latest Business News
- SMS S (stock name) for latest news




Offline
After receiving huge response to its follow on public offering,
We have made a calculation on the kind of gains that an investor would have made while investing in the FPO. Though on the face of it the returns appear to be modest. In reality the annualized returns for the 15-day period during which the investor locks in his money is over 100%. So it seems investing in IPOs seem to be a much more profitable option for those looking at listing gains as against the modest returns his money earns by parking his money in bank savings and fixed deposits.


